BioSyent Inc.
BIOYFOTCHealthcare● Active
$9.97
+$0.16(+1.63%)
Market Cap$114040030
P/E Ratio—
52W High$12
52W Low$7.63
BioSyent Inc. (BIOYF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BIOYF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
$0.14
Revenue
$0.01B
Est. $0.01B · +9.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat Revenue
BIOYF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 25, 2026 | — | — | — | — | $0.01B | — |
| — Q2 FY2026 | May 14, 2026 | — | $0.14 | — | $0.01B | $0.01B | +9.5% |
| — Q1 FY2026 | Mar 19, 2026 | — | $0.12 | — | $0.01B | $0.01B | -6.1% |
| — Q3 FY2025 | Aug 21, 2025 | — | $0.13 | — | $0.01B | $0.01B | -23.8% |
| — Q2 FY2025 | May 15, 2025 | — | $0.14 | — | $0.01B | $0.01B | -25.9% |
| ▼ Q1 FY2025 | Mar 11, 2025 | $0.10 | $0.10 | -8.8% | $0.01B | $0.01B | -32.8% |
| ▲ Q4 FY2024 | Nov 20, 2024 | $0.10 | $0.15 | +42.8% | $0.02B | $0.01B | +167.5% |
| ▲ Q3 FY2024 | Aug 26, 2024 | $0.09 | $0.10 | +3.2% | $0.01B | $0.01B | +1.7% |
Q3 FY2026
Aug 25, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026
EPS Actual
$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2026
Mar 19, 2026
EPS Actual
$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2025
Aug 21, 2025
EPS Actual
$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
May 15, 2025
EPS Actual
$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 11, 2025Miss
EPS Actual
$0.10
EPS Est.
$0.10
EPS Surpr.
-8.8%
Revenue
$0.01B
Q4 FY2024
Nov 20, 2024Beat
EPS Actual
$0.15
EPS Est.
$0.10
EPS Surpr.
+42.8%
Revenue
$0.02B
Q3 FY2024
Aug 26, 2024Beat
EPS Actual
$0.10
EPS Est.
$0.09
EPS Surpr.
+3.2%
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 14, 2026 | — | $10.61 | $10.58 | -0.28% |
| — Q1 FY2026 | Mar 19, 2026 | — | $11.18 | $11.00 | -1.61% |
| — Q3 FY2025 | Aug 21, 2025 | — | $8.40 | $8.15 | -2.98% |
| — Q2 FY2025 | May 15, 2025 | — | $7.70 | $7.70 | +0.00% |
| ▼ Q1 FY2025 | Mar 11, 2025 | -8.8% | $7.48 | $7.51 | +0.40% |
| ▲ Q4 FY2024 | Nov 20, 2024 | +42.8% | $7.91 | $8.00 | +1.14% |
| ▲ Q3 FY2024 | Aug 26, 2024 | +3.2% | $7.58 | $7.58 | +0.00% |
| ▲ Q2 FY2024 | May 16, 2024 | +85.7% | $6.25 | $6.26 | +0.16% |
Q2 FY2026-0.28%
Report Date
May 14, 2026
EPS Beat/Miss
—
Price Before
$10.61
Price After
$10.58
Q1 FY2026-1.61%
Report Date
Mar 19, 2026
EPS Beat/Miss
—
Price Before
$11.18
Price After
$11.00
Q3 FY2025-2.98%
Report Date
Aug 21, 2025
EPS Beat/Miss
—
Price Before
$8.40
Price After
$8.15
Q2 FY2025+0.00%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$7.70
Price After
$7.70
Q1 FY2025+0.40%
Report Date
Mar 11, 2025
EPS Beat/Miss
-8.8%
Price Before
$7.48
Price After
$7.51
Q4 FY2024+1.14%
Report Date
Nov 20, 2024
EPS Beat/Miss
+42.8%
Price Before
$7.91
Price After
$8.00
Q3 FY2024+0.00%
Report Date
Aug 26, 2024
EPS Beat/Miss
+3.2%
Price Before
$7.58
Price After
$7.58
Q2 FY2024+0.16%
Report Date
May 16, 2024
EPS Beat/Miss
+85.7%
Price Before
$6.25
Price After
$6.26
Avg Beat Reaction+0.43%
Avg Miss Reaction+0.40%
Beat Rate3 / 8 quarters
Largest Move-2.98% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BIOYF ends December
BioSyent Inc. (BIOYF) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.14 (in line with the analyst consensus of —). The next BIOYF earnings date is expected around September 1, 2026.
Each quarter, investors track BIOYF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIOYF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BIOYF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BIOYF earnings · 4 questionsBioSyent Inc.'s next earnings report is expected around September 1, 2026. BIOYF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIOYF historically reports after market close (AMC).
BIOYF earnings datewhen is BIOYF earningsBIOYF next earnings datewhen does BIOYF report earningsBIOYF earnings calendar
▸ Source: FMP · BioSyent Inc. SEC filings · US GAAP · BioSyent Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026